Cargando…
Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure
PURPOSE: To evaluate the cost-effectiveness of long-term domiciliary high flow nasal cannula (HFNC) treatment in COPD patients with chronic respiratory failure. PATIENTS AND METHODS: A cohort of 200 COPD patients were equally randomized into usual care ± HFNC and followed for 12 months. The outcome...
Autores principales: | Sørensen, Sabrina Storgaard, Storgaard, Line Hust, Weinreich, Ulla Møller |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219115/ https://www.ncbi.nlm.nih.gov/pubmed/34168472 http://dx.doi.org/10.2147/CEOR.S312523 |
Ejemplares similares
-
Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure
por: Storgaard, Line Hust, et al.
Publicado: (2018) -
Development in PaCO(2) over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula—post-hoc analysis from a randomised controlled trial
por: Storgaard, Line Hust, et al.
Publicado: (2020) -
A Real-Life Study of Combined Treatment with Long-Term Non-Invasive Ventilation and High Flow Nasal Cannula in Patients with End-Stage Chronic Obstructive Lung Disease
por: Weinreich, Ulla Møller, et al.
Publicado: (2023) -
The Danish respiratory society guideline for long-term high flow nasal cannula treatment, with or without supplementary oxygen
por: Weinreich, Ulla Møller, et al.
Publicado: (2023) -
The effect of domiciliary high flow nasal cannula treatment on dyspnea and walking distance in patients with interstitial lung disease – A pilot study
por: Weinreich, Ulla Møller, et al.
Publicado: (2022)